CohBar, Inc.
1455 Adams Drive
Suite 2050
Menlo Park, CA 94025
United States
650 446 7888
https://www.cohbar.com
版塊: Healthcare
行業: Biotechnology
全職員工: 9
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Dr. Pinchas Cohen Dean, M.D. | Founder & Member of Scientific Advisory Board | 65.25k | 無 | 1957 |
| Dr. Nir Yacov Barzilai M.D. | Founder & Member of Scientific Advisory Board | 65.25k | 無 | 1956 |
| Dr. John M. Amatruda M.D., Ph.D. | Co-Founder | 31.5k | 無 | 1946 |
| Ms. Jordyn Tarazi | Director of Investor Relations | 無 | 無 | 無 |
截止 2021年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。
描述
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
公司管治
截至 無 止，CohBar, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
